Skip to content

Author

Nagendra Verma

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Regulatory Convergence in Cell and Gene Therapy: Harmonizing Quality, CMC, and Approval Pathways Across the FDA, EMA, PMDA, and Emerging Markets

Cell and gene therapies (CGTs) have progressed from proof of concept to an established commercial pipeline, yet global translation remains constrained by fragmented regulatory frameworks; heterogeneous Chemistry, Manufacturing, and Controls (CMC) requirements; and divergent approval pathways. This narrative review comp...

Nagendra Verma, Swati Arora · 0 citations
Review Open access Sep 2026

Tiny Messengers, Actionable Targets: sEV-Driven Epigenetic Changes in Cancer

Small extracellular vesicles (sEVs) are pivotal mediators of intercellular epigenetic communication in cancer. Following MISEV2023, we use the size- and isolation-based term sEV throughout, because most primary studies cited here cannot resolve which biogenetic route generated the vesicles they analyzed. By selectively...

Nagendra Verma, Swati Arora, Katrina Croghan · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.